Clinical Trial Update: SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing short-course radiotherapy versus long-course radiotherapy followed by a PD-L1 inhibitor plus CAPEOX as total neoadjuvant therapy in loca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• PD-L1 inhibitor (Programmed death-ligand 1 inhibitor)

Snippet

Sponsor: Shandong Provincial Hospital | Conditions: Rectal Cancer, Advanced Stage Colorectal Cancer | Phase 2 | Status: RECRUITING